Literature DB >> 5762041

The time course of action of (-)-hyoscine after intramuscular injection.

J J Brand.   

Abstract

1. Although (-)-hyoscine has been in clinical use for many years, there is little detailed information concerning the speed of absorption or duration of action of the drug after single intramuscular doses.2. The time course of action of the drug was therefore examined using biological methods, and measurements were made of saliva flow, pulse rate, pupil diameter and mental alertness for up to 8 hr after doses of 0.4, 0.2, 0.1 and 0.05 mg of the hydrobromide.3. These techniques gave comparable results and peak activity was achieved at 1-2 hr after dose and followed by a gradual decline over the 8 hr period.4. The results are compared with those of earlier experiments of a similar kind, and discussed in relation to their bearing on both therapeutics and experimental design.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5762041      PMCID: PMC1703087          DOI: 10.1111/j.1476-5381.1969.tb07981.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Effect of drugs on motion sickness produced by short exposures to artificial waves.

Authors:  E M GLASER; R A McCANCE
Journal:  Lancet       Date:  1959-04-25       Impact factor: 79.321

2.  Absorption from nasal mucous membrane: systemic effect of hyoscine following intranasal administration.

Authors:  J TONNDORF; R W HYDE; H I CHINN; J E LETT
Journal:  Ann Otol Rhinol Laryngol       Date:  1953-09       Impact factor: 1.547

3.  Experiments on the side-effects of drugs.

Authors:  E M GLASER
Journal:  Br J Pharmacol Chemother       Date:  1953-06

4.  The prevention of seasickness with hyoscine, benadryl, and phenergan.

Authors:  E M GLASER; G R HERVEY
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

5.  Further experiments on the prevention of motion sickness.

Authors:  E M GLASER; G R HERVEY
Journal:  Lancet       Date:  1952-03-08       Impact factor: 79.321

6.  Side-effects of 1-hyoscine and cyclizine studied by objective tests.

Authors:  J J Brand; W P Colquhoun; W L Perry
Journal:  Aerosp Med       Date:  1968-09

7.  (--)-Hyoscine and cyclizine as motion sickness remedies.

Authors:  J J Brand; W P Colquhoun; A H Gould; W L Perry
Journal:  Br J Pharmacol Chemother       Date:  1967-08

8.  Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods.

Authors:  J J Brand; W L Perry
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

9.  Ocular manifestations of parenteral administration of scopolamine (hyoscine).

Authors:  K S Mehra; P Chandra; B B Khare
Journal:  Br J Ophthalmol       Date:  1965-10       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.